TheraScreen EGFR29 Mutation & K-RAS Mutation Tests
EGFR
- A critical biomarker in non-small cell lung cancer (NSCLC)
- Detects 29 of the most frequent EGFR mutations
K-RAS
- A critical biomarker in metastatic colorectal cancer (mCRC)
- Detects seven of the most frequent K-RAS mutations
“The TheraScreen®: K-RAS Mutation Kit is intended “ to aid doctors to identify colorectal cancer patients who may not benefit from anti-EGFR therapies such as cetuximab or panitumumab.”